J.W. Cole Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$459K	Hold	20,632	–	–	0.02%	520
2025 Q4	$551K	Buy	20,632 +501	+2%	+$12K	0.01%	853
2025 Q3	$430K	Buy	20,131 +150	+0.8%	+$3.55K	0.01%	1055
2025 Q2	$431K	Sell	19,981 -3,045	-13%	-$56.6K	0.01%	970
2025 Q1	$382K	Buy	23,026 +5,406	+31%	+$98.2K	0.01%	861
2024 Q4	$323K	Hold	17,620	–	–	0.01%	755
2024 Q3	$271K	Hold	17,620	–	–	0.01%	809
2024 Q2	$286K	Hold	17,620	–	–	0.01%	718
2024 Q1	$326K	Hold	17,620	–	–	0.02%	664
2023 Q4	$552K	Hold	17,620	–	–	0.03%	458
2023 Q3	$367K	Sell	17,620 -265	-1%	-$7.2K	0.03%	503
2023 Q2	$428K	Hold	17,885	–	–	0.03%	464
2023 Q1	$337K	Hold	17,885	–	–	0.02%	564
2022 Q4	$285K	Hold	17,885	–	–	0.02%	578
2022 Q3	$293K	Hold	17,885	–	–	0.02%	543
2022 Q2	$252K	Sell	17,885 -25	-0.1%	-$467	0.02%	599
2022 Q1	$434K	Hold	17,910	–	–	0.03%	497
2021 Q4	$418K	Hold	17,910	–	–	0.03%	532
2021 Q3	$297K	Hold	17,910	–	–	0.02%	361
2021 Q2	$437K	Buy	17,910 +25	+0.1%	+$564	0.03%	468
2021 Q1	$461K	Sell	17,885 -544	-3%	-$23.9K	0.04%	403
2020 Q4	$985K	Sell	18,429 -775	-4%	-$38.5K	0.1%	225
2020 Q3	$792K	Buy	19,204 +1,284	+7%	+$55.4K	0.06%	305
2020 Q2	$869K	Buy	+17,920	New	+$860K	0.13%	176
2020 Q1	–	Sell	-22,042	Closed	-$943K	–	103
2019 Q4	$943K	Buy	+22,042	New	+$959K	0.12%	196